Osorio JC+, Knorr DA, Weitzenfeld P, Blanchard L, Yao N, Baez M, Sevilla C, DiLillo M, Rahman J, Sharma VP, Bromberg J, Postow MA, Ariyan C, Robson ME, Ravetch JV. Fc-optimized CD40 agonistic antibody elicits tertiary lymphoid structure formation and systemic antitumor immunity in metastatic cancer. Cancer Cell. 2025 Aug 14 (Inpress). https://doi.org/10.1016/j.ccell.2025.07.013. +Corresponding author
Gómez-Banoy N, Ortiz EJ, Jiang CS, Dagher C, Sevilla C, Girshman J, Pagano AM, Plodkowski AJ, Zammarrelli WA, Mueller JJ, Aghajanian C, Weigelt B, Makker V, Cohen P, Osorio JC+. Body mass index and adiposity influence responses to immune checkpoint inhibition in endometrial cancer. J Clin Invest. 2024 Jun 20;134(17):e180516. doi: 10.1172/JCI180516. PMID: 38900575; PMCID: PMC11364395. +Corresponding author
Osorio JC+, Smith P, Knorr DA, Ravetch JV. The antitumor activities of anti-CD47 antibodies require Fc-FcγR interactions. Cancer Cell. 2023 Dec 11;41(12):2051-2065.e6. doi: 10.1016/j.ccell.2023.10.007. Epub 2023 Nov 16. PMID: 37977147; PMCID: PMC10842210. +Corresponding author